Novavax AB
556549-4019ActiveInnovating vaccines using proprietary technology platform and strategic partnerships.
Yleiskatsaus
- 100–199
- Työntekijät
- 500–1000milj SEK
- Liikevaihto
- 1997
- Perustettu
Avainpäättäjät
Rick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
+18 lisää yhteystietoja Funnelfeedrissä
Kuvaus
Novavax is a company dedicated to developing life-saving vaccine innovations to prevent serious illness and eradicate disease globally. They leverage a proprietary, cutting-edge technology platform featuring recombinant protein-based nanoparticles and their specialized Matrix-M® adjuvant. This platf...
Tunnisteet
Avainsanat
Teknologiat
Yritystiedot
- Toimiala
- Annan naturvetenskaplig och teknisk forskning och utveckling
- Oikeudellinen muoto
- Aktiebolag
- ALV-numero
- SE556549401901
Päättäjät
22 yhteystietoa FunnelfeedrissäRick Crowley
Executive Vice President, Chief Operations Officer
Jane Shershenovich
Vice President, Chief Intellectual Property Counsel, Legal
Jim Kelly
Executive Vice President, Chief Financial Officer and Treasurer
Elaine O’Hara
Executive Vice President, Chief Strategy Officer
Rachel King
Director
Ian Watkins
Executive Vice President, Chief Human Resources Officer
David Mott
Director
Rick Rodgers, MBA
Director
Robert Walker, MD
Senior Vice President, Chief Medical Officer
Ruxandra Draghia-Akli, MD, PhD
Executive Vice President, Head of Research & Development
Richard Douglas, PhD
Director
Margaret G. McGlynn, R. Ph.
Chairman of the Board of Directors
Silvia Taylor
Executive Vice President, Chief Corporate Affairs Officer and Head of Novavax Sweden
Troy Morgan, JD
Senior Vice President Deputy General Counsel & Chief Compliance Officer
Gregg Alton
Director
Mark Casey
Executive Vice President, Chief Legal Officer
John Shiver, PhD
Director
Charles Newton
Director
John C. Jacobs
President and Chief Executive Officer
Kumar Singh Saikatendu
Head of Translational Medicine team
Gretchen Earle
Senior Director, Global Program Management
Henrietta Ukwu, MD
Executive Vice President, Chief Regulatory Officer
Samankaltaiset yritykset
20 samankaltaista yritystä Funnelfeedrissä
VALNEVA SWEDEN AB
Specialty vaccine company developing, manufacturing, and commercializing prophylactic vaccines.
Bavarian Nordic Sweden AB
1–4 työntekijätPioneering global developer and manufacturer of life-saving vaccines.
Abera Bioscience AB
Developing next-generation nasal vaccines using modular OMV platform technology.
ARGENX BV
1–4 työntekijätEngineering life-changing immunology solutions for severe autoimmune diseases.
VACARA AB
1–4 työntekijätSwedish biotech developing RA diagnostics, vaccines, and therapeutics.
Selaa lisää
Kysymyksiä yrityksestä Novavax AB
Haluatko nähdä Funnelfeedrin toiminnassa?
Varaa ilmainen demo ja tutustu siihen, miten Funnelfeedr auttaa sinua löytämään ja konvertoimaan ihanteelliset asiakkaasi.
Varaa demo